Navigation Links
Microbix Sales Grow 22% For Nine Months
Date:8/6/2009

s attractive to many commercial players. The Microbix technology has the potential to provide a new entry company with full IP exclusivity. As previously reported term sheet agreements have already been signed with artificial insemination companies worldwide."

Urokinase

The Company acquired all Urokinase assets from ImaRx Therapeutics, Inc. of Tucson, Arizona, (Nasdaq: IMRX) in September 2008. These assets included ImaRx' remaining Urokinase inventory as well as the regulatory file for the product (formerly known as Abbokinase(R), now rebranded as Kinlytic(R)), key raw materials for Urokinase manufacturing, and the corresponding sales and marketing infrastructure.

"The results of our Urokinase investment have been disappointing," Mr. Gastle said. "The US FDA has not yet released the inventory of Kinlytic we acquired in September 2008. We purchased the Urokinase inventory on the premise that it was stable and releasable under an FDA approvable letter. While the FDA has conceded the data we presented has merit, at a recent meeting of appeal the FDA requested yet more stability data before they will reconsider our request. No clinical trials have been requested in order to obtain inventory release for labeled indications. The Company is currently evaluating all options for the inventory."

Microbix is one of many drug companies that are experiencing delays at the FDA today and continues to press matters with the agency," Mr. Gastle said. "We remain optimistic that we will reach the market."

Other Highlights

The Company has reduced its overhead as we transitioned virology manufacturing into the new facility. A major corporate objective is to be profitable and cash flow positive in 2010. With the additional capacity we expect to expand sales in 2010 and to see continued financial improvement for
'/>"/>

SOURCE Microbix Biosystems Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Microbix Files First Patent Applications On Novel Technology Platform For Large Semen Sexing Market
2. Microbix Sales Grow Over 30% In The Second Quarter; Up 43% In The First Half 09
3. Microbix Announces A New Technology Platform For The SST Project
4. Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline
5. Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009
6. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
7. iCardiac Expands Sales and Marketing Team
8. Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
9. New Director of Lab Sales for Polymathic Analytical Labs
10. Peregrine Pharmaceuticals to Present at the Jesup & Lamont 2009 Growth Stock & National Sales Conference
11. Global One Consulting Announces Exclusive Contract to Expand Saigene Biotech, Inc. Sales in Emerging Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Research ... "Global Enzyme for Pulp & Paper Industry Report ... The Global Enzyme for Pulp & Paper Industry Report ... current state of the global enzyme for pulp & ... overview of the industry including definitions, classifications, applications and ...
(Date:8/27/2014)... Palm Beach County, Florida (PRWEB) August 27, 2014 ... & Company Inc. (SCI) is announcing the creation ... board’s priority is to take the SCI’s philosophy ... insuring the company’s research and development actions are ... interpretations. , This new Scientific Advisory Board provides ...
(Date:8/27/2014)... College, PA (PRWEB) August 27, 2014 ... Simulation Software with new features for the biomedical ... is an enhanced Biological Thermal Sensor, exclusive to the ... a specialty version of XFdtd, developed to calculate the ... export functionality has been added to all versions to ...
(Date:8/26/2014)... 26, 2014  NeuroSigma, Inc., a Los ... bioelectronic technologies, today announced that it has filed a ... and Exchange Commission relating to a proposed initial public ... to be offered and the price range for the ... Jefferies LLC will act as the book-running manager for ...
Breaking Biology Technology:Global Enzyme for Pulp & Paper Industry Report 2014 2New Sancilio & Company, Inc. Scientific Board 2New Sancilio & Company, Inc. Scientific Board 3Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 2Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 3
... 3 Sangamo BioSciences,Inc. (Nasdaq: SGMO ) announced ... will provide an update on the progress of,Sangamo,s ZFP ... strategy at 12:45pm (PT) on Wednesday, October 10, 2007,at ... will be webcast live and may be accessed via ...
... Cadence Pharmaceuticals,Inc. (Nasdaq: CADX ), a biopharmaceutical ... candidates principally,for use in the hospital setting, announced ... will present the corporate overview on,Wednesday, October 10, ... Eastern Time),during the BIO Investor Forum in San ...
... Laboratories to 45%, GURGAON, India, Oct. 3 ... announced the,signing of Definitive Agreements, providing for an increase ... 45% at a price of Rs. 160 per share,aggregating ... of shares from the existing Promoters (b) Preferential ...
Cached Biology Technology:Sangamo BioSciences to Present at the 2007 BIO InvestorForum 2Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at BIO Investor Forum 2Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology 2Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology 3
(Date:8/27/2014)... Outstanding basic research, a growing focus on translating ... care have earned the Herbert Irving Comprehensive Cancer ... and NewYork-Presbyterian Hospital an $18 million, five-year Cancer ... (NCI). The grant renews the center,s status as ... in New York City and one of only ...
(Date:8/27/2014)... of studies have shown that excessive iron ... Parkinson,s disease. Previous studies from Chunyan Guo ... China have shown that baicalin prevented iron ... metal transporter 1 expression, and increased ferroportin ... rotenone-induced Parkinson,s disease rats. However, the relationship ...
(Date:8/27/2014)... ago the Happy Camp Complex of fires had consumed ... complex had consumed 35,530 as of eight hours ago. ... Happy Camp Ranger District of the Klamath National Forest ... 11, 2014. All but three of those fires are ... of contained fires and their size at containment: Delta, ...
Breaking Biology News(10 mins):Herbert Irving Comprehensive Cancer Center awarded $18 million grant 2Herbert Irving Comprehensive Cancer Center awarded $18 million grant 3Herbert Irving Comprehensive Cancer Center awarded $18 million grant 4Happy Camp and July Fire Complexes in California 2
... The TWAS 22nd General Meeting will take place on ... Theoretical Physics (ICTP), home to the Academy,s secretariat. TWAS,s ... by Romain Murenzi, executive director of TWAS; Fernando Quevedo, ... Affairs, Italy; and Jacob Palis, TWAS President, will highlight ...
... American Heart Association will today present Gladstone Institutes ... PhD, with the 2011 AHA Distinguished Scientist Award, ... founding cardiovascular scientists. The Distinguished Scientist Award ... Association can give a scientist. Dr. Mahley is ...
... 2 million people each year, is caused primarily by infectious ... Mtb . Mtb targets human immune cells as ... body,s immune response. Up until now, scientists ... the Immunity and Infection Research Centre at Vancouver Coastal Health ...
Cached Biology News:TWAS 22nd General Meeting in Trieste 2Gladstone founder receives American Heart Association Distinguished Scientist Award 2Researchers uncover why the body can't defend against tuberculosis 2